Optical imaging detects apoptosis in the brain and peripheral organs of prion-infected mice

Journal of Neuropathology and Experimental Neurology

Volumn 70, Issue 2, 2011, Pages 143-150

  Drew, Simon C ^a,b,c   Haigh, Cathryn L ^a   Klemm, Helen M J ^a   Masters, Colin L ^a   Collins, Steven J ^a   Barnham, Kevin J ^a,b   Lawson, Victoria A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MAX PLANCK INSTITUTE FOR CHEMICAL ENERGY CONVERSION   (Germany)

Author keywords

Apoptosis; Caspase; Fluorescence; Mice; Optical imaging; Prion

Indexed keywords

CASPASE; CASPASE 3; CASPASE INHIBITOR; PRION PROTEIN; PROCASPASE 3; SULFORHODAMINE B VALYLALANYLASPARTATE FLUOROMETHYLKETONE; UNCLASSIFIED DRUG;

AFFINITY LABELING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN; BRAIN REGION; CELL LOSS; CONTROLLED STUDY; ENZYME ACTIVATION; FLUORESCENCE IMAGING; ILEUM; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; KIDNEY; LUNG; MOUSE; NERVE CELL; NONHUMAN; PRION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN LOCALIZATION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BRAIN; CASPASES; DISEASE PROGRESSION; ENZYME ACTIVATION; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; PRION DISEASES; PRIONS; PRPSC PROTEINS; RHODAMINES; TISSUE DISTRIBUTION;

EID: 79251594896     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/NEN.0b013e3182084a8c     Document Type: Article

References (46)

1. Chan SL, Mattson MP. Caspase and calpain substrates: Roles in synaptic plasticity and cell death. J Neurosci Res 1999;58:167-90
2. Shimohama S. Apoptosis in Alzheimer's diseaseVAn update. Apoptosis 2000;5:9-16
3. Ventimiglia R, Lau L-F, Kinloch RA, et al. Role of caspases in neuronal apoptosis. Drug Dev Res 2001;52:515-33
4. Alnemri ES, Livingston DJ, Nicholson DW, et al. Human ICE/CED-3 protease nomenclature. Cell 1996;87:171
5. Ribe EM, Serrano-Saiz E, Akpan N, et al. Mechanisms of neuronal death in disease: Defining the models and the players. Biochem J 2008;415: 165-82
6. Liberski PP, Sikorska B, Bratosiewicz-Wasik J, et al. Neuronal cell death in transmissible spongiform encephalopathies (prion diseases) revisited: From apoptosis to autophagy. Int J Biochem Cell Biol 2004;36: 2473-90
7. Giese A, Groschup MH, Hess B, et al. Neuronal cell death in scrapie-infected mice is due to apoptosis. Brain Pathol 1995;5:213-21
8. Jamieson E, Jeffrey M, Ironside JW, et al. Apoptosis and dendritic dysfunction precede prion protein accumulation in 87V scrapie. Neuroreport 2001;12:2147-53
9. Lucassen PJ, Williams A, Chung WC, et al. Detection of apoptosis in murine scrapie. Neurosci Lett 1995;198:185-88
10. Jesionek-Kupnicka D, Buczynski J, Kordek R, et al. Programmed cell death (apoptosis) in Alzheimer's disease and Creutzfeldt-Jakob disease. Folia Neuropathol 1997;35:233-35
11. Puig B, Ferrer I. Cell death signaling in the cerebellum in Creutzfeldt-Jakob disease. Acta Neuropathol 2001;102:207-15
12. Hetz C, Russelakis-Carneiro M, Maundrell K, et al. Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein. Embo J 2003;22:5435-45
13. Hetz C, Russelakis-Carneiro M, Walchli S, et al. The disulfide isomerase Grp58 is a protective factor against prion neurotoxicity. J Neurosci 2005; 25:2793-802
14. Brazier MW, Lewis V, Ciccotosto GD, et al. Correlative studies support lipid peroxidation is linked to PrP(res) propagation as an early primary pathogenic event in prion disease. Brain Res Bull 2006;68: 346-54
15. Kuida K, Zheng TS, Na S, et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 1996;384:368-72
16. Talanian RV, Quinlan C, Trautz S, et al. Substrate specificities of caspase family proteases. J Biol Chem 1997;272:9677-82
17. Van Noorden CJ. The history of Z-VAD-FMK, a tool for understanding the significance of caspase inhibition. Acta Histochem 2001;103:241-51
18. Lawson VA, Stewart JD, Masters CL. Enzymatic detergent treatment protocol that reduces protease-resistant prion protein load and infectivity from surgical-steel monofilaments contaminated with a human-derived prion strain. J Gen Virol 2007;88:2905-14
19. Tateishi J, Ohta M, Koga M, et al. Transmission of chronic spongiform encephalopathy with kuru plaques from humans to small rodents. Ann Neurol 1979;5:581-84
20. Griffin RJ, Williams BW, Bischof JC, et al. Use of a fluorescently labeled poly-caspase inhibitor for in vivo detection of apoptosis related to vascular-targeting agent arsenic trioxide for cancer therapy. Technol Cancer Res Treat 2007;6:651-54
21. White AR, Enever P, Tayebi M, et al. Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature 2003;422:80-83
22. Benavides SH, Monserrat AJ, Farina S, et al. Sequential histochemical studies of neuronal lipofuscin in human cerebral cortex from the first to the ninth decade of life. Arch Gerontol Geriatr 2002;34:219-31
23. Brunk UT, Terman A. Lipofuscin: Mechanisms of age-related accumulation and influence on cell function. Free Radic Biol Med 2002;33: 611-19
24. Schonenbrucher H, Adhikary R, Mukherjee P, et al. Fluorescence-based method, exploiting lipofuscin, for real-time detection of central nervous system tissues on bovine carcasses. J Agric Food Chem 2008;56: 6220-26
25. Seehafer SS, Pearce DA. You say lipofuscin, we say ceroid: Defining autofluorescent storage material. Neurobiol Aging 2006;27:576-88
26. Transmissible subacute spongiform encephalopathies: Prion disease. In: Kretzschmar HA, Giese A, Brown DR, et al, eds. Proceedings of the Third International Symposium on Transmissible Subacute Spongi-form Encephalopathies: Prion Disease. Val-de-Grace, Paris, France. Amsterdam/Oxford, Paris: Elsevier; 1996:97-106
27. Ford MJ, Burton LJ, Morris RJ, et al. Selective expression of prion protein in peripheral tissues of the adult mouse. Neuroscience 2002;113: 177-92
28. Bosque PJ, Ryou C, Telling G, et al. Prions in skeletal muscle. Proc Natl Acad Sci USA 2002;99:3812-17
29. Glatzel M, Abela E, Maissen M, et al. Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med 2003;349: 1812-20
30. Head MW, Ritchie D, Smith N, et al. Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: An immu-nohistochemical, quantitative, and biochemical study. Am J Pathol 2004; 164:143-53
31. Herzog C, Riviere J, Lescoutra-Etchegaray N, et al. PrPTSE distribution in a primate model of variant, sporadic, and iatrogenic Creutzfeldt-Jakob disease. J Virol 2005;79:14339-45
32. Jewell JE, Brown J, Kreeger T, et al. Prion protein in cardiac muscle of elk (Cervus elaphus nelsoni) and white-tailed deer (Odocoileus virginianus) infected with chronic wasting disease. J Gen Virol 2006;87:3443-50
33. Peden AH, Ritchie DL, Head MW, et al. Detection and localization of PrPSc in the skeletal muscle of patients with variant, iatrogenic, and sporadic forms of Creutzfeldt-Jakob disease. Am J Pathol 2006;168: 927-35
34. Thomzig A, Cardone F, Kruger D, et al. Pathological prion protein in muscles of hamsters and mice infected with rodent-adapted BSE or vCJD. J Gen Virol 2006;87:251-54
35. Thomzig A, Kratzel C, Lenz G, et al. Widespread PrPSc accumulation in muscles of hamsters orally infected with scrapie. EMBO Rep 2003;4: 530-33
36. Trifilo MJ, Yajima T, Gu Y, et al. Prion-induced amyloid heart disease with high blood infectivity in transgenic mice. Science 2006;313:94-97
37. Heikenwalder M, Zeller N, Seeger H, et al. Chronic lymphocytic inflammation specifies the organ tropism of prions. Science 2005;307: 1107-10
38. Kitamoto T, Mohri S, Tateishi J. Organ distribution of proteinase-resistant prion protein in humans and mice with Creutzfeldt-Jakob disease. J Gen Virol 1989;70:3371-79
39. Lawson VA, Furness JB, Klemm HM, et al. The brain to gut pathway: A possible route of prion transmission. Gut 2010;59:1643-51
40. Radebold K, Chernyak M, Martin D, et al. Blood borne transit of CJD from brain to gut at early stages of infection. BMC Infect Dis 2001;1:20
41. Brown P, Gibbs CJ Jr, Rodgers-Johnson P, et al. Human spongiform encephalopathy: The National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994;35:513-29
42. Gribble GW. Fluoroacetate toxicity. J Chem Educ 1973;50:460-62
43. Slee EA, Zhu H, Chow SC, et al. Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD-fmk) inhibits apoptosis by blocking the processing of CPP32. Biochem J 1996;315(Pt 1):21-24
44. Cotman CW, Anderson AJ. A potential role for apoptosis in neuro-degeneration and Alzheimer's disease. Mol Neurobiol 1995;10:19-45
45. Cheong WF, Prahl SA, Welch AJ. A review of the optical properties of biological tissues. IEEE J Quantum Electron B 1990;26:2166-85
46. Hintersteiner M, Enz A, Frey P, et al. In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe. Nat Biotechnol 2005;23:577-83